July 23, 2020 – Sumitovant Biopharma executive Mary Stutts has joined the advisory board of executive search firm Slone Partners. Ms. Stutts is a renowned C-level global branding and growth expert who has provided strategic counsel in the biotechnology, healthcare, technology, and media industries at Fortune 200 companies including Genentech, Bayer, Bristol Myers Squibb, Kaiser Permanente, UnitedHealth Group, and Comcast NBCUniversal.
“Mary Stutts brings many years of life sciences business leadership experience and perspectives to our firm at a time when we are renewing its commitment to diversity and inclusion,” said Tara Kochis-Stach, president of Slone Partners. “I believe that Mary will help shape the future of Slone Partners as we continue to grow and improve the level of service that we provide to our client partners and candidates.”
Growing up as a foster child from the age of five, Ms. Stutts in 2004 founded The Center for Excellence in Life (TCEL), a 501c3 organization focused on developing women and underrepresented youth aspiring to leadership positions. She later served as chief inclusion, diversity & health equity officer at Stanford Health Care (SHC), where she worked directly with the SHC board of directors and executive committee to build and curate an Inclusive Leadership Program for Stanford’s leaders. Ms. Stutts is currently the senior vice president of corporate relations at Sumitovant Biopharma.
Ms. Stutts is a highly-respected corporate advisor, author, and speaker on the dynamics of women and men in leadership, developing a personal brand, mastering entrepreneurship, and the imperative for women leaders to add value in growing corporations. Her current book, “The Missing Mentor: Women Advising Women on Power, Progress and Priorities,” is regularly listed among the top sellers on the topic of women in leadership. Named one of Savoy Magazine’s 2019 Most Influential Women in Corporate America, Ms. Stutts earned a B.A. in Communications Management from the University of Louisiana, a Master’s Degree in Health Administration from the University of Southern California, and completed the Executive Program on Organization and Strategy at the Stanford Graduate School of Business.
“I am honored and delighted to become a member of the advisory board of Slone Partners as I am a firm believer in the company’s mission and its people,” said Ms. Stutts. “In my role, I will bring my voice, perspective and insights as a seasoned black female executive to the table, and help solidify Slone’s leadership and commitment to diversity and inclusion, both within the company and within the candidate pools that we deliver to our client partners.”
Ms. Stutts joins Vijay Aggarwal, Bijan Salehizadeh, Mara G. Aspinall, and Kyle Wilson as members of the advisory board of Slone Partners.
Dr. Aggarwal has over 30 years of experience in both pharmaceutical services and clinical diagnostics. In addition to serving as managing partner of The Channel Group, Dr. Aggarwal provides strategic advisory services to companies with operations or investments in the clinical diagnostics, molecular diagnostic and anatomic pathology sectors. He is also active with several investment banks and angel investment groups in the healthcare market.
Dr. Salehizadeh was welcomed to the Slone Partners advisory board in 2014. He currently serves as co-founder and managing director at NaviMed Capital, a Washington, D.C. based private investment firm focused on growth capital healthcare investments.
Ms. Aspinall is a healthcare industry leader and pioneer with a commitment to civic involvement. She is the president and CEO of Health Catalysts, an investment and advisory firm dedicated to the growth of new healthcare companies.
Shifting Needs in Life Sciences Attract Non-Traditional Talent
To keep up with the mind-bending changes that are coursing through the life sciences sector, recruiters who specialize in this area are keeping an open mind to new possibilities in their own work.
As Leslie Loveless, CEO of Slone Partners explains, the life sciences industry has become increasingly consumer-centric, opening the door for recruiting more talent from outside the field. In addition, exciting progress in areas like gene-editing, and the promise it holds, has piqued the interest of many executives who in the past would have given the sciences a wide berth. An entrepreneurial spirit permeates much of the industry, and that has also attracted non-traditional talent.
Mr. Wilson is an investment banker driving innovation in the life science research tools and diagnostic markets. He joined the Slone Partners advisory board in 2015 and currently serves as a partner with BroadOak Capital Partners.
Slone Partners is a nationally recognized senior-level recruitment provider that specializes in delivering executive, management and leadership talent for the diagnostic, biopharmaceutical, healthcare information technology and laboratory testing industries. The firm has offices in Boston, New York, Washington, D.C., and San Francisco. Recently, Slone Partners was included among Hunt Scanlon Media’s “Top 50 Healthcare & Life Sciences Search Firms.”
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media